CAS: 587841-73-4 - ZCL278
- Synonyms:
- 2-(4-broMo-2-chlorophenoxy)-N-(4-(N-(4,6-diMethylpyriMidin-2-yl)sulfaMoyl)phenylcarbaMothioyl)acetaMide
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | ZCL278 REF: TM-T1855CAS: 587841-73-4 | 96.29% - 99.72% | 51.00 €~791.00 € | Wed 15 Jan 25 |
 | ZCL 278 REF: 3D-MYA84173CAS: 587841-73-4 | Min. 95% | To inquire | Wed 19 Feb 25 |
 | 2-(4-broMo-2-chlorophenoxy)-N-(4-(N-(4,6-diMethylpyriMidin-2-yl)sulfaMoyl)phenylcarbaMothioyl)acetaMide REF: IN-DA00ECF0CAS: 587841-73-4 | 95% | - - - | Discontinued product |
ZCL278
CAS:587841-73-4
ZCL278 is a selective Cdc42 GTPase inhibitor.
Formula:
C21H19BrClN5O4S2
Purity:
96.29% - 99.72%
Color and Shape:
Solid
Molecular weight:
584.89
- Inhibitors
- Cell Cycle/Checkpoint
- CDK
- Ras
- See more categories
- Cancer Research Antibodies
Ref: TM-T1855
| 5mg | 51.00 € | ||
| 10mg | 79.00 € | ||
| 25mg | 136.00 € | ||
| 50mg | 221.00 € | ||
| 100mg | 311.00 € | ||
| 200mg | 497.00 € | ||
| 500mg | 791.00 € | ||
| 1mL*10mM (DMSO) | 79.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
ZCL 278
CAS:587841-73-4
ZCL 278 is a molecule that has been shown in animal models to inhibit the …
Formula:
C21H19BrClN5O4S2
Purity:
Min. 95%
Molecular weight:
584.89 g/mol
Ref: 3D-MYA84173
| 10mg | 222.00 € | ||
| 100mg | 884.00 € |
Estimated delivery in United States, on Wednesday 19 Feb 2025
2-(4-broMo-2-chlorophenoxy)-N-(4-(N-(4,6-diMethylpyriMidin-2-yl)sulfaMoyl)phenylcarbaMothioyl)acetaMide
CAS:587841-73-4
Formula:
C21H19BrClN5O4S2
Purity:
95%
Color and Shape:
Solid
Molecular weight:
584.8937
Ref: IN-DA00ECF0
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
